BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30499364)

  • 1. Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients.
    Matsumoto T; Matsui T; Hirano F; Tohma S; Mori M
    Mod Rheumatol; 2020 Jan; 30(1):78-84. PubMed ID: 30499364
    [No Abstract]   [Full Text] [Related]  

  • 2. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.
    Saraux A; Benichou J; Guillevin L; Idbrik L; Job-Deslandre C; Sibilia J; Soudant M; Wendling D; Guillemin F
    Clin Exp Rheumatol; 2015; 33(5):602-10. PubMed ID: 26315585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases.
    Yamazaki S; Shimbo A; Akutsu Y; Takase H; Morio T; Mori M
    Pediatr Rheumatol Online J; 2020 Mar; 18(1):26. PubMed ID: 32293465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
    Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
    Favalli EG; Pontikaki I; Becciolini A; Biggioggero M; Ughi N; Romano M; Crotti C; Gattinara M; Gerloni V; Marchesoni A; Meroni PL
    Clin Rheumatol; 2017 Aug; 36(8):1747-1755. PubMed ID: 28597133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study.
    Felis-Giemza A; Chmurzyńska K; Kołodziejczyk B; Gazda A
    Rheumatol Int; 2023 Jul; 43(7):1307-1311. PubMed ID: 36859560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register.
    McErlane F; Foster HE; Davies R; Lunt M; Watson KD; Symmons DP; Hyrich KL
    Rheumatology (Oxford); 2013 Oct; 52(10):1905-13. PubMed ID: 23873820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease.
    Relas H; Kosola S
    Clin Rheumatol; 2019 Mar; 38(3):785-791. PubMed ID: 30374749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.
    Lee WJ; Briars L; Lee TA; Calip GS; Suda KJ; Schumock GT
    Pharmacotherapy; 2016 Dec; 36(12):1201-1209. PubMed ID: 27779782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).
    Davies R; Carrasco R; Foster HE; Baildam EM; Chieng SEA; Davidson JE; Ioannou Y; Wedderburn LR; Thomson W; Hyrich KL
    Semin Arthritis Rheum; 2016 Oct; 46(2):190-195. PubMed ID: 27422803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Adults With Polyarticular Juvenile Idiopathic Arthritis to Adults With Rheumatoid Arthritis: A Cross-sectional Analysis of Clinical Features and Medication Use.
    Feger DM; Longson N; Dodanwala H; Ostrov BE; Olsen NJ; June RR
    J Clin Rheumatol; 2019 Jun; 25(4):163-170. PubMed ID: 29781829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases.
    Oliveira Ramos F; Rodrigues A; Magalhaes Martins F; Melo AT; Aguiar F; Brites L; Azevedo S; Duarte AC; Furtado C; Mourão AF; Sequeira G; Cunha I; Figueira R; Melo Gomes JA; Santos MJ; Fonseca JE
    RMD Open; 2021 Nov; 7(3):. PubMed ID: 34819385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry.
    Kavanaugh A; Keystone E; Greenberg JD; Reed GW; Griffith JM; Friedman AW; Saunders KC; Ganguli A
    Rheumatology (Oxford); 2017 Jul; 56(7):1095-1101. PubMed ID: 28340006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].
    Bukovac LT; Vidović M; Lamot L; Perica M; Harjacek M;
    Reumatizam; 2013; 60(1):57-66. PubMed ID: 24003687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
    Kamata Y; Minota S
    Rheumatol Int; 2018 Apr; 38(4):663-668. PubMed ID: 29204683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
    Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
    Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan.
    Miyamae T; Tanaka E; Kishi T; Matsuyama T; Igarashi T; Fujikawa S; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2015 Jan; 25(1):62-6. PubMed ID: 25019624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt.
    Mourão AF; Santos MJ; Melo Gomes JA; Martins FM; Mendonça SC; Oliveira Ramos F; Fernandes S; Salgado M; Guedes M; Carvalho S; Costa JA; Brito I; Duarte C; Furtado C; Lopes A; Rodrigues A; Sequeira G; Branco JC; Fonseca JE; Canhão H
    Rheumatology (Oxford); 2016 Apr; 55(4):697-703. PubMed ID: 26672905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan.
    Hirata A; Suenaga Y; Miyamura T; Matsui T; Tohma S; Suematsu E; Ohnaka K; Takayanagi R
    Int J Rheum Dis; 2018 Apr; 21(4):828-835. PubMed ID: 27126059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up].
    Strickler AL; Cifuentes D; Mihovilovic K; Vergara F; Grez M; Rivera V
    Rev Chil Pediatr; 2020 Aug; 91(4):521-528. PubMed ID: 33399728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.